Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study
Top Cited Papers
- 7 July 2015
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 21 (11), 1020-1026
- https://doi.org/10.1016/j.cmi.2015.06.028
Abstract
No abstract availableKeywords
Funding Information
- Gilead (355728)
- BMS (Q-45-1397-08-42)
- Roche Pharmaceuticals (B100TSH0110005.9245)
This publication has 29 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infectionJournal of Hepatology, 2012
- Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic reviewBMC Infectious Diseases, 2011
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and IsraelLiver International, 2011
- Hepatitis B prevention and control: Lessons from the East and the WestWorld Journal of Hepatology, 2011
- Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of TurkeyInternational Journal of Infectious Diseases, 2009
- The changing epidemiology of hepatitis C virus infection in EuropeJournal of Hepatology, 2007
- Chronic hepatitis BHepatology, 2007
- Trends in Hepatitis B and Hepatitis C Virus among Blood Donors over 16 Years in TurkeyEuropean Journal of Epidemiology, 2006
- Prevalence of Hepatitis C in adults in the south-eastern region of Anatolia: a community-based studyHepatology Research, 2004
- The epidemiology of hepatitis C in turkeyInfection, 1994